Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients.
Abstract
Data di Pubblicazione:
2008
Citazione:
Efficacy and safety of increasing doses of the cyclophilin inhibitor Debio 025 in combination with pegylated Interferon alpha-2a in treatment naïve mono-infected HCV patients / R., Flisiak; S. V., Feinman; M., Jablkowski; A., Horban; W., Kryczka; W., Halota; J. E., Heathcote; G., Mazzella; Vandelli, Carmen; J. S., Liz; R., Crabbé; P., Scalfaro; H., Porchet. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - STAMPA. - 48:2(2008), pp. S62-S62. ( 43rd Annual Meeting of the European Association for the Study of the Liver Milan, Italy 23-27 April 2008) [10.1016/S0168-8278(08)60145-2].
Abstract:
WITHOUT ABSTRACT
Tipologia CRIS:
Abstract in Atti di Convegno
Keywords:
cyclophilin inhibitor Debio 025; HCV patients.
Elenco autori:
R., Flisiak; S. V., Feinman; M., Jablkowski; A., Horban; W., Kryczka; W., Halota; J. E., Heathcote; G., Mazzella; Vandelli, Carmen; J. S., Liz; R., Crabbé; P., Scalfaro; H., Porchet
Link alla scheda completa:
Titolo del libro:
Abstracts of the 43rd Annual Meeting of the European Association for the Study of the Liver
Pubblicato in: